title: Cannabinoids for pediatric epilepsy? Up in smoke or real science?
abstract: Public interest in the use of "medical marijuana" for the treatment of childhood epilepsy has burgeoned in the last few years. This has occurred in parallel with a growing interest in "medical marijuana" in general. Physicians and pediatricians must balance their patients' desire for immediate access to these products with the tenets of evidence-based medicine. This review discusses the biochemistry of cannabis products (the phytocannabinoids) setting this in the context of the endogenous endocannabinoid system. The differing and potentially modulating effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are reviewed. The evidence-base supporting or not the use of cannabis products for the treatment of neurological disease and specifically epilepsy is explored. The potential for adverse effects and particularly of neurotoxicity is addressed. Finally, public health and sociocultural implications are touched upon. Specific recommendations for interested physicians are provided including advocacy for patients and for a change in the "scheduling" of cannabis in order to better foster much-needed high-quality scientific research in this important area.
authors.affiliation: Division of Pediatric Neurology, University of Utah School of Medicine and Primary Children's Hospital, Division of Pediatric Neurology, Salt Lake City, USA.
authors.forename: Francis M
authors.initials: FM
authors.lastname: Filloux
keywords: Cannabidiol (CBD); cannabis; epilepsy; medical marijuana; tetrahydrocannabinol (THC)
references.citation: Am J Ther. 2016 Mar-Apr;23 (2):e601-5
references.pmid: 24413371
references.citation: Mayo Clin Proc. 2012 Feb;87(2):172-86
references.pmid: 22305029
references.citation: Physiol Rev. 2009 Jan;89(1):309-80
references.pmid: 19126760
references.citation: Expert Opin Drug Metab Toxicol. 2013 Sep;9(9):1219-28
references.pmid: 23621668
references.citation: Drug Metab Pharmacokinet. 2013;28(4):332-8
references.pmid: 23318708
references.citation: Exp Clin Psychopharmacol. 2011 Jun;19(3):231-42
references.pmid: 21480730
references.citation: ACS Chem Neurosci. 2014 Nov 19;5(11):1131-41
references.pmid: 25029033
references.citation: Neurology. 2002 Nov 12;59(9):1337-43
references.pmid: 12427880
references.citation: Br J Psychiatry. 2010 Oct;197(4):259-60
references.pmid: 20884945
references.citation: Med Sci Monit. 2011 Dec;17(12):RA249-61
references.pmid: 22129912
references.citation: Annu Rev Neurosci. 2012;35:529-58
references.pmid: 22524785
references.citation: Rambam Maimonides Med J. 2013 Oct 29;4(4):e0022
references.pmid: 24228165
references.citation: Expert Rev Neurother. 2013 Feb;13(3 Suppl 1):15-9
references.pmid: 23369055
references.citation: Mult Scler. 2012 Feb;18(2):219-28
references.pmid: 21878454
references.citation: Neuropharmacology. 1986 Apr;25(4):441-6
references.pmid: 3012403
references.citation: PLoS One. 2013;8(2):e55821
references.pmid: 23390554
references.citation: Pharmacotherapy. 2013 Feb;33(2):195-209
references.pmid: 23386598
references.citation: Epilepsia. 2014 Jun;55(6):783-6
references.pmid: 24854149
references.citation: Trends Pharmacol Sci. 2009 Oct;30(10):515-27
references.pmid: 19729208
references.citation: Front Public Health. 2013 Oct 10;1:42
references.pmid: 24350211
references.citation: Pharmacol Ther. 2012 Jan;133(1):79-97
references.pmid: 21924288
references.citation: J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):437S-448S
references.pmid: 6975285
references.citation: Prog Neurobiol. 2010 Nov;92(3):370-85
references.pmid: 20624444
references.citation: Seizure. 2012 Jun;21(5):344-52
references.pmid: 22520455
references.citation: Schizophr Bull. 2014 Mar;40(2):287-99
references.pmid: 24342821
references.citation: Br J Pharmacol. 2011 Aug;163(7):1344-64
references.pmid: 21749363
references.citation: Pediatrics. 2015 Mar;135(3):584-7
references.pmid: 25624383
references.citation: Soc Work Public Health. 2014;29(2):121-31
references.pmid: 24405197
references.citation: Pharmacology. 1980;21(3):175-85
references.pmid: 7413719
references.citation: Br J Pharmacol. 2013 Oct;170(3):679-92
references.pmid: 23902406
references.citation: Annu Rev Physiol. 2009;71:283-306
references.pmid: 19575681
references.citation: Schizophr Res. 2011 Aug;130(1-3):216-21
references.pmid: 21592732
references.citation: Brain. 2012 Jul;135(Pt 7):2245-55
references.pmid: 22669080
references.citation: J Pharmacol Exp Ther. 2010 Feb;332(2):569-77
references.pmid: 19906779
references.citation: S Afr Med J. 1986 Jan 4;69(1):14
references.pmid: 3941934
references.citation: Drug Alcohol Depend. 2009 Nov 1;105(1-2):139-53
references.pmid: 19656642
references.citation: Curr Drug Abuse Rev. 2008 Jun;1(2):114-23
references.pmid: 19630711
references.citation: N Engl J Med. 2015 Mar 12;372(11):991-3
references.pmid: 25760352
references.citation: JAMA. 2014 Jun 18;311(23):2377-8
references.pmid: 24845238
references.citation: JAMA Pediatr. 2013 Jul;167(7):630-3
references.pmid: 23712626
references.citation: Eur J Pharmacol. 2008 May 13;585(2-3):441-52
references.pmid: 18413273
references.citation: Br J Psychiatry. 2010 Oct;197(4):285-90
references.pmid: 20884951
references.citation: J Neuroimmune Pharmacol. 2013 Jun;8(3):608-20
references.pmid: 23471521
references.citation: Ther Adv Neurol Disord. 2012 Sep;5(5):255-66
references.pmid: 22973422
references.citation: Addiction. 2013 Apr;108(4):733-40
references.pmid: 23216690
references.citation: Cochrane Database Syst Rev. 2012 Jun 13;(6):CD009270
references.pmid: 22696383
references.citation: Pharmacotherapy. 2012 Apr;32(4):340-53
references.pmid: 22422635
references.citation: Br J Pharmacol. 2008 Jan;153(2):199-215
references.pmid: 17828291
references.citation: Curr Psychiatry Rep. 2013 Dec;15(12):419
references.pmid: 24234874
references.citation: Neurology. 2014 Apr 29;82(17):1556-63
references.pmid: 24778283
references.citation: Neurology. 2014 May 27;82(21):1879-87
references.pmid: 24789863
references.citation: Epilepsy Behav. 2015 Apr;45:49-52
references.pmid: 25845492
references.citation: Epilepsy Curr. 2014 Sep;14(5):250-2
references.pmid: 25346628
references.citation: Epilepsia. 2015 Aug;56(8):1246-51
references.pmid: 26114620
references.citation: Epilepsy Behav. 2013 Dec;29(3):574-7
references.pmid: 24237632
references.citation: PLoS One. 2014 Mar 26;9(3):e92816
references.pmid: 24671103
references.citation: J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):449S-463S
references.pmid: 6271840
references.citation: Epilepsia. 2014 Jun;55(6):791-802
references.pmid: 24854329
references.citation: Br J Clin Pharmacol. 2011 May;71(5):758-65
references.pmid: 21204913
references.citation: Pediatrics. 2015 Mar;135(3):e769-85
references.pmid: 25624385